Publications by authors named "Sarah Long"

Background: Medial malleolus fractures (MMFs) are common across the world. Currently, there is a lack of consensus on the number of screws used in fixation of MMF. Our aim was to compare the radiographic outcomes of MMF with patients between fractures that have either undergone single-screw (SS) or dual-screw (DS) fixation.

View Article and Find Full Text PDF

Background: The transition period of becoming a new paediatric registrar has limited study. Consequently, the learning needs of such trainees are unclear including educational interventions that may improve the process. This qualitative study examined the negative and positive experiences of transitioning paediatric trainees to identify learning needs and subsequently derive educational interventions that are perceived to ease transition.

View Article and Find Full Text PDF
Article Synopsis
  • On June 17, 2024, the FDA approved the 21-valent pneumococcal conjugate vaccine (PCV21) for adults 18 and older, introducing eight new serotypes not in other vaccines.
  • The ACIP recommends PCV21 for all adults 65 and older, and for those aged 19-64 with specific health risks if they haven't been previously vaccinated or their vaccination status is unknown.
  • ACIP recommends a single dose of PCV21 for adults 19 and older, while maintaining previous indications and guidelines for other pneumococcal vaccines.
View Article and Find Full Text PDF
Article Synopsis
  • Respiratory syncytial virus (RSV) is a significant cause of respiratory issues and hospitalizations in older adults during fall and winter in the U.S., prompting new vaccination recommendations.
  • For the 2023-2024 season, a single dose of FDA-approved RSV vaccines is now recommended for all adults aged 75 and older, and for those aged 60-74 who are at higher risk for severe RSV.
  • The updated guidelines aim to improve vaccination rates among high-risk groups and include ongoing monitoring of vaccine effectiveness and safety to inform future decisions.
View Article and Find Full Text PDF

Introduction: Ongoing advances in genetic technology may soon provide prenatal screening for multiple genetic conditions.

Aims: The aims were to investigate what prenatal screening test characteristics women prioritise and their willingness to pay for these tests.

Methods: We designed an online survey incorporating a series of discrete choice scenarios.

View Article and Find Full Text PDF

Background: Responsive deep brain stimulation (rDBS) uses physiological signals to deliver stimulation when needed. rDBS is hypothesized to reduce stimulation-induced speech effects associated with continuous DBS (cDBS) in patients with essential tremor (ET).

Objective: To determine if rDBS reduces cDBS speech-related side effects while maintaining tremor suppression.

View Article and Find Full Text PDF

Exhausted CD8 T cells (T) are associated with worse outcome in cancer yet better outcome in autoimmunity. Building on our past findings of increased TIGITKLRG1 T with teplizumab therapy in type 1 diabetes (T1D), in the absence of treatment we found that the frequency of TIGITKLRG1 T is stable within an individual but differs across individuals in both T1D and healthy control (HC) cohorts. This TIGITKLRG1 CD8 T population shares an exhaustion-associated EOMES gene signature in HC, T1D, rheumatoid arthritis (RA), and cancer subjects, expresses multiple inhibitory receptors, and is hyporesponsive , together suggesting co-expression of TIGIT and KLRG1 may broadly define human peripheral exhausted cells.

View Article and Find Full Text PDF

Background: Many approaches to management of medial malleolar fractures are described in the literature however, their morphology is under investigated. The aim of this study was to analyse the morphology of medial malleolar fractures to identify any association with medial malleolar fracture non-union or malunion.

Methods: Patients who had undergone surgical fixation of their MMF were identified from 2012 to 2022, using electronic patient records.

View Article and Find Full Text PDF
Article Synopsis
  • Respiratory syncytial virus (RSV) is a major cause of hospitalization for infants in the U.S., leading to recommended preventative measures like nirsevimab (Bevfortus) for infants and the newly approved RSVpreF vaccine (Abrysvo) for pregnant individuals.
  • The FDA approved the RSVpreF vaccine in August 2023 for administration during weeks 32-36 of pregnancy to help protect infants under 6 months from RSV-related respiratory issues.
  • The CDC's Advisory Committee on Immunization Practices recommends that either the RSVpreF vaccine for mothers or nirsevimab for infants be used to protect against RSV, but not necessarily both for most infants.
View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is a cause of severe respiratory illness in older adults. In May 2023, the Food and Drug Administration approved the first vaccines for prevention of RSV-associated lower respiratory tract disease in adults aged ≥60 years. Since May 2022, the Advisory Committee on Immunization Practices (ACIP) Respiratory Syncytial Virus Vaccines Adult Work Group met at least monthly to review available evidence regarding the safety, immunogenicity, and efficacy of these vaccines among adults aged ≥60 years.

View Article and Find Full Text PDF
Article Synopsis
  • * Before 2021, the main vaccines recommended were the 23-valent pneumonia vaccine (PPSV23) alone or in combination with the 13-valent pneumococcal conjugate vaccine (PCV13), which was later updated to include the new 15-valent (PCV15) and 20-valent (PCV20) vaccines.
  • * Current ACIP recommendations suggest using PCV20 alone or PCV15 with PPSV23 for adults 65 and older or those
View Article and Find Full Text PDF
Article Synopsis
  • - Respiratory syncytial virus (RSV) is the top reason for hospitalizations in U.S. infants, and in July 2023, the FDA approved a new treatment called nirsevimab to help prevent RSV-related lung infections in infants and young kids.
  • - The ACIP has been reviewing nirsevimab's safety and effectiveness since October 2021, and in August 2023, recommended it for all infants under 8 months in their first RSV season and for at-risk children up to 19 months entering their second season.
  • - Nirsevimab is expected to be given mainly from October to March, based on RSV patterns from before the COVID-19 pandemic, and it can significantly
View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is a cause of severe respiratory illness in older adults. In May 2023, the Food and Drug Administration approved the first vaccines for prevention of RSV-associated lower respiratory tract disease in adults aged ≥60 years. Since May 2022, the Advisory Committee on Immunization Practices (ACIP) Respiratory Syncytial Virus Vaccines Adult Work Group met at least monthly to review available evidence regarding the safety, immunogenicity, and efficacy of these vaccines among adults aged ≥60 years.

View Article and Find Full Text PDF

Increased mitotic activity is associated with the genesis and aggressiveness of many cancers. To assess the clinical value of mitotic activity as prognostic biomarker, we performed a pan-cancer study on the mitotic network activity index (MNAI) constructed based on 54-gene mitotic apparatus network. Our pan-cancer assessment on TCGA (33 tumor types, 10,061 patients) and validation on other publicly available cohorts (23 tumor types, 9,209 patients) confirmed the significant association of MNAI with overall survival, progression-free survival, and other prognostic endpoints in multiple cancer types, including lower-grade gliomas (LGG), breast invasive carcinoma (BRCA), as well as many others.

View Article and Find Full Text PDF

Purpose: The purpose of this study is to examine perceptions and experiences of women who donate human milk and highlight various aspects of the breast milk donation process.

Study Design: A cross-sectional descriptive study.

Methods: An online survey was conducted with a convenience sample of women who donated milk at several milk banks in the United States.

View Article and Find Full Text PDF

Prenatal screening has evolved rapidly following the introduction of non-invasive prenatal testing (NIPT), with screening now available for an increasing number of conditions. We explored the attitudes and expectations of women within the context of using NIPT to detect multiple different single gene and chromosome conditions during pregnancy. An online survey was used to assess these issues with a sample of 219 women from Western Australia.

View Article and Find Full Text PDF

Reviewed by Sarah Long, lecturer in veterinary dermatology at Bristol vet school.

View Article and Find Full Text PDF

Bile salt hydrolases (BSHs) are currently being investigated as target enzymes for metabolic regulators in humans and as growth promoters in farm animals. Understanding structural features underlying substrate specificity is necessary for inhibitor design. Here, we used a multidisciplinary workflow including mass spectrometry, mutagenesis, molecular dynamic simulations, machine learning, and crystallography to demonstrate substrate specificity in Lactobacillus salivarius BSH, the most abundant enzyme in human and farm animal intestines.

View Article and Find Full Text PDF

Intracranial electroencephalography (iEEG) presents a unique opportunity to extend human neuroscientific understanding. However, typically iEEG is collected from patients diagnosed with focal drug-resistant epilepsy (DRE) and contains transient bursts of pathological activity. This activity disrupts performances on cognitive tasks and can distort findings from human neurophysiology studies.

View Article and Find Full Text PDF

The 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc, a subsidiary of Pfizer, Inc]) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Merck Sharp & Dohme LLC]) have been recommended for U.S. children, and the recommendations vary by age group and risk group (1,2).

View Article and Find Full Text PDF

Modifications at the glycolate moiety of englerin A were made to explore variations at the most sensitive site on the molecule for activity in the NCI 60 screen, wherein englerin A is highly potent and selective for renal cancer cells. Replacement of the glycolate by other functionalities as well as esterification of the glycolate hydroxyl yielded compounds which displayed excellent selectivity and potency compared with the natural product. TRPC4/5 ion channel experiments with five compounds showed delayed or reduced agonism with TRPC5, at much higher concentrations than englerin A.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session5lu1mc55um11v13tl3p81d2n70tq9tg3): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once